aztreonam has been researched along with Bacteriuria in 4 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Bacteriuria: The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A well-controlled comparative study was conducted in order to evaluate the efficacy, safety and usefulness of the monobactam antibiotic aztreonam (AZT) in complicated urinary tract infections (UTI) using cefoperazone (CPZ) as the control drug." | 9.06 | [Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections]. ( Kawamura, N; Kishi, H; Kumamoto, Y; Kumon, H; Naide, Y; Niijima, T; Nishiura, T; Ohkoshi, M; Ohmori, H; Sakai, S, 1986) |
| "A well-controlled comparative study was conducted in order to evaluate the efficacy, safety and usefulness of the monobactam antibiotic aztreonam (AZT) in complicated urinary tract infections (UTI) using cefoperazone (CPZ) as the control drug." | 5.06 | [Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections]. ( Kawamura, N; Kishi, H; Kumamoto, Y; Kumon, H; Naide, Y; Niijima, T; Nishiura, T; Ohkoshi, M; Ohmori, H; Sakai, S, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zapardiel, J | 1 |
| Nieto, E | 1 |
| Soriano, F | 1 |
| Roberts, JA | 1 |
| Millar, MR | 1 |
| Inglis, T | 1 |
| Ewing, R | 1 |
| Clark, P | 1 |
| Williams, RE | 1 |
| Lacey, RW | 1 |
| Ohmori, H | 1 |
| Kumon, H | 1 |
| Kumamoto, Y | 1 |
| Sakai, S | 1 |
| Niijima, T | 1 |
| Kishi, H | 1 |
| Ohkoshi, M | 1 |
| Kawamura, N | 1 |
| Naide, Y | 1 |
| Nishiura, T | 1 |
1 review available for aztreonam and Bacteriuria
| Article | Year |
|---|---|
Role of aztreonam in urinary tract infections.
Topics: Aztreonam; Bacteriuria; Clinical Trials as Topic; Cross Infection; Drug Resistance, Microbial; Human | 1988 |
3 trials available for aztreonam and Bacteriuria
| Article | Year |
|---|---|
Role of aztreonam in urinary tract infections.
Topics: Aztreonam; Bacteriuria; Clinical Trials as Topic; Cross Infection; Drug Resistance, Microbial; Human | 1988 |
Double-blind study comparing aztreonam with placebo for prophylaxis of infection following prostatic surgery.
Topics: Aztreonam; Bacteriuria; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Postoperative C | 1987 |
[Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections].
Topics: Adolescent; Adult; Aged; Aztreonam; Bacteriuria; Cefoperazone; Clinical Trials as Topic; Female; Gra | 1986 |
1 other study available for aztreonam and Bacteriuria
| Article | Year |
|---|---|
Evaluation of a new selective medium for the isolation of Corynebacterium urealyticum.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteriuria; Colony Count, Microbial; Corynebacterium; Co | 1998 |